The Senate Finance Committee today held a hearing on the Children’s Health Insurance Program, which covers 8.9 million children with family incomes above Medicaid eligibility limits who lack access to affordable private coverage. While the program is authorized through Oct. 1, 2019, legislative action is needed to continue funding beyond this month. The Medicaid and CHIP Payment and Access Commission, created by the CHIP Reauthorization Act of 2009 to advise Congress on issues affecting Medicaid and CHIP, projects that three states and the District of Columbia will exhaust available federal funds in the first quarter of FY 2018 and another 27 will do so in the second quarter. Committee Chairman Orrin Hatch (R-UT), who with Sen. Ted Kennedy (D-MA) led bipartisan efforts to establish the program in 1997, said, “The basic question is: Does the committee want to reauthorize or merely extend CHIP? Reauthorization would entail more extensive debate and the consideration of potential policy changes to the underlying program.” Sen. Ron Wyden (D-OR), ranking member of the committee, said, “It’s important for Congress to take action soon. There’s no kicking this can down the road with a short-term bill.” Testifying at the hearing were the mother of a CHIP recipient and officials from MACPAC and the Virginia Department of Medical Assistance Services. For more on CHIP, see the AHA’s new infographic.

Related News Articles

Headline
The AHA collaborated with LCMC Health in New Orleans to spotlight innovative efforts that extend care beyond hospital walls. LCMC Health supports families…
Headline
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2026 health coverage via the Health Insurance…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
A new report from KFF reveals that Medicare Advantage enrollees had access to just 48% of the physicians available to Traditional Medicare beneficiaries in…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…